Research and Healthcare Resources ("RAHR") for Technology Outcomes Framework Agreement

Genomics England is a company wholly owned and funded by the Department for Health & Social Care. Our vision is a world where everyone benefits from genomic healthcare. Where genomic data and research are translated rapidly into clinical interpretations, insights, and actions, driving better patient outcomes and lower healthcare costs.

To capitalise on the opportunities within the genomic healthcare sector, and to support the delivery of the government's strategy over the next several years, Genomics England will be developing its services to increase its value offering and keep pace within rapidly growing biotech and life science sectors.

Delivering our aims will involve multiple projects and programmes focused on making improvements in different areas. Genomics England's internal expertise will not always be sufficient to realise the required outcomes therefore Genomics England will draw on external partners with the necessary expertise and capacity to support delivery by establishing a framework of partners to supply the following types of services across Lots:

Lot 1 a Design and Research Services - onshore Lot 1 b Design and Research Services - offshore

Lot 2 a Data services - onshore Lor 2 b Data services - offshore

Lot 3 a Bioengineering services - onshore Lot 3 b Bioengineering services - offshore

Lot 4 a Engineering services - onshore Lot 4 b Engineering Services - offshore

Lot 5 a IT strategy and architecture services - onshore Lot 5 b IT strategy and architecture services - offshore

Lot 6 a Management services - onshore Lot 6 b Management Services - offshore

Lot 7 a Additional services - onshore Lot 7 b Additional services - offshore

Lot 8 Service Integrators

Across Lots 1 - 7, suppliers may bid for multiple Lots and may provide a tender for onshore or offshore or both.

This Contract Notice is issued to notify all interested potential suppliers of a procurement to establish a framework agreement in line with Regulation 33 of the Public Contracts Regulations 2015. The framework has a maximum value of.£50,000,000. The Authority will enter into 2 year framework agreements with successful Tenderers, with the potential for extension period(s). The maximum value over the initial 2 years is £25,000,000.

The framework will encompass Research and Healthcare Resource providers to deliver technology outcome-based projects.

The framework will have multiple suppliers and have a number of different Lots. Suppliers will be able to bid for one or multiple Lots either as a single entity or in collaboration with other organisations.

Interested suppliers are invited to view more information regarding the opportunity and download the tender documents. You may need to register on Bravo if you have not already done so: https://public.bravosolution.co.uk/genomicsengland/web/login.html . Once registered, please search for the project under code itt_2011